KalVista Pharmaceuticals (KALV) Other Gross PP&E Adjustments: 2014-2024
Historic Other Gross PP&E Adjustments for KalVista Pharmaceuticals (KALV) over the last 6 years, with Dec 2024 value amounting to -$9.5 million.
- KalVista Pharmaceuticals' Other Gross PP&E Adjustments was N/A to -$9.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$33.3 million, marking a year-over-year change of. This contributed to the annual value of -$4.7 million for FY2024, which is N/A change from last year.
- According to the latest figures from Q4 2024, KalVista Pharmaceuticals' Other Gross PP&E Adjustments is -$9.5 million, which was up 3.01% from -$9.8 million recorded in Q4 2024.
- In the past 5 years, KalVista Pharmaceuticals' Other Gross PP&E Adjustments ranged from a high of $1.6 million in Q2 2020 and a low of -$9.8 million during Q4 2024.
- In the last 2 years, KalVista Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$9.0 million in 2023 and averaged -$8.5 million.
- The largest annual percentage gain for KalVista Pharmaceuticals' Other Gross PP&E Adjustments in the last 5 years was 14.97% (2020), contrasted with its biggest fall of 1,881.40% (2020).
- KalVista Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at -$1.7 million in 2020, then declined by 11.74% to -$1.9 million in 2021, then reached -$9.0 million in 2023, then dropped by 8.52% to -$9.5 million in 2024.
- Its Other Gross PP&E Adjustments stands at -$9.5 million for Q4 2024, versus -$9.8 million for Q4 2024 and -$9.4 million for Q3 2024.